安心交易
不成功退款,无后顾之忧,风险服务升级。The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal's readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
《临床血脂学杂志》的出版是为了支持各种各样的医学专业人员,他们致力于降低血脂异常和相关脂质代谢紊乱的发病率和死亡率。该杂志的读者群涵盖了医学界的广泛领域,包括心脏病学家、内分泌学家和初级保健医师,以及参与治疗糖尿病、高血压和肥胖等疾病的人。该杂志还介绍了治疗上述患者基础的联合健康专家,如药剂师、护士和营养师。由于临床血脂学的范围很广,该杂志所讨论的主题也同样多样。典型文章探讨了在治疗环境中进行的脂质学,药理学研究的最新进展,治疗和试验报告,案例研究,生活方式改变的影响,以及对从业者感兴趣的类似学术材料。虽然优先选择直接实用的材料,但支持血脂学的科学是由专家贡献者提出的,以便我们的读者可以立即获得循证方法来减少心血管和冠心病。该杂志的各部分将介绍开创性研究和开展这些研究的临床医生、案例研究、伦理标准和行为、专业指导,如ATP和NCE、编辑评论、读者来信、国家脂质协会(NLA)新闻和即将发布的事件信息,以及NLA年度科学报告的摘要。各分会在适当时举行的会议和科学论坛。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | PHARMACOLOGY & PHARMACY 药学 | 2区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | PHARMACOLOGY & PHARMACY | Q1 | 5.365 |
安心交易
不成功退款,无后顾之忧,风险服务升级。合规备案认证机构
资质许可齐全,合规经营,用户权益有保障。正刊保障
刊物在国家新闻出版署网可查,抵制假刊、增刊。对公账户资金监管
交易均通过对公账户,资金安全有保障。01 选择服务并上传稿件 我们的学术顾问将根据您的需求推荐适合的服务
02 分配资深编辑和同行专家 根据您的服务方案和研究方向,为您分配资深编辑和同行专家
03 交付及反馈 每个环节的服务会在您审阅和确认后进行下一步,根据您的反馈和建议做调整
04 提升稿件质量 我们将基于您的反馈并平衡期刊的投稿要求,为您进一步优化稿件
05 提交投稿 出版专家将在您确认定稿后,为您整理并检查所有必须文件,协助您完成期刊投稿。
06 投稿跟进 及时查询稿件状态,协助您与期刊编辑沟通,根据审稿意见协助修正文章
07 拒稿支持 若期刊拒稿,您可通过拒稿咨询服务发掘稿件的改进方案,并获取365天无限次向同期刊或其他期刊的重投服务